Literature DB >> 28559510

Rapid detection of in vitro antituberculous drug resistance among smear-positive respiratory samples using microcolony detection-based direct drug susceptibility testing method.

Irim Iftikhar1, Seema Irfan1, Joveria Farooqi1, Zahida Azizullah1, Rumina Hasan1.   

Abstract

BACKGROUND: With the rise in multidrug-resistant tuberculosis, there is a search for newer techniques that will rapidly detect drug-resistant Mycobacterium tuberculosis. Although molecular techniques can detect resistance, culture is still considered gold standard, especially in resource-limited settings where quick, cheap, and easy techniques are needed. The aim of the study was to evaluate microcolony method thin layer agar (TLA) for quick detection of resistance against the first- and second-line antituberculous drugs in clinical isolates. This was a cross-sectional study performed at Aga Khan University Hospital.
MATERIAL AND METHODS: A total of 87 Z-N stain smear-positive pulmonary samples were received and indirect drug susceptibility test (ID-DST) was performed using Lowenstein-Jensen and mycobacteria growth indicator tube. Direct DST was performed using TLA on 7H10 agar. TLA was observed twice weekly under microscope for 4 weeks. Sensitivity, specificity, and accuracy were calculated for TLA using indirect susceptibility method as the gold standard. Level of agreement was calculated using Kappa score.
RESULTS: TLA showed sensitivity of 89% and 95.2% for isoniazid and rifampicin, while for ethionamide, ofloxacin, and injectable aminoglycosides, it was 96.6%, 92.1%, and 100%, respectively. Specificity for the first-line drugs was >95% while second-line drugs ranged from 70% to 100%. Mean time to positivity was 10.2 days by TLA as compared to 43.1 days by ID-DST.
CONCLUSIONS: TLA is a quick and reliable method in identifying resistance, especially in resource-limited settings. However, additional liquid culture can be set up as backup, especially in patients on therapy to avoid false negative results.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28559510     DOI: 10.4103/ijmy.ijmy_41_17

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  2 in total

1.  Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.

Authors:  Irina Kontsevaya; Jim Werngren; Yen Holicka; Kadri Klaos; Anh Tran; Vladyslav Nikolayevskyy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-30       Impact factor: 3.267

2.  GeneXpert assay - A cutting-edge tool for rapid tissue diagnosis of tuberculous lymphadenitis.

Authors:  Raadhika Raja; P N Sreeramulu; Prakash Dave; D Srinivasan
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-11-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.